Estimates Revisions Maravai LifeSciences Holdings, Inc.
Stocks
MRVI
US56600D1072
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
15:18:10 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 5.885 USD | +1.82% |
|
-5.84% | +81.08% |
| 08-07 | Deutsche Bank Adjusts Maravai Lifesciences PT to $8 From $6, Maintains Buy Rating | MT |
| 08-06 | Maravai LifeSciences Holdings, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- MRVI Stock
- Consensus Maravai LifeSciences Holdings, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
